Pemafibrate ameliorates renal injury through induction of FGF21 and ketone body production in male mice
Physiological Reports · 2025-02 · 13 (3)
DOI: 10.14814/phy2.70135 ↗At a glance
Journal article in Physiological Reports, published online on 2025-01-30. Written by Kunihiko Takahara and 11 co-authors. Institution: Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Major MEDLINE topics: Fibroblast Growth Factors, Butyrates, Ketone Bodies. Cited 4 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY 4.0). Funded by: Grant-in-Aid for Scientific Research A, Takeda Science Foundation (TSF), Grant-in-Aid for Scientific Research C.
Abstract (original language)
Chronic kidney disease is a life‐threatening disease worldwide. PPARα is a crucial transcriptional regulator of lipid metabolism and inflammation. Here, we examine whether a novel selective PPARα modulator, pemafibrate modulates renal injury in a model of unilateral ureteral obstruction (UUO). Administration of pemafibrate to wild‐type (WT) mice led to reduction of renal dysfunction and fibrosis after UUO with accompanying increases in plasma levels of fibroblast growth factor (FGF) 21 and ketone body β‐hydroxybutyrate (BHB). Treatment of WT mice with FGF21 or BHB precursor resulted in attenuation of renal fibrotic and inflammatory responses after UUO. Treatment of proximal tubular cells with FGF21 or BHB reduced expression of epithelial–mesenchymal transition markers. These findings suggest that pemafibrate could ameliorate renal damage, at least in part, by its abilities to increase the production of FGF21 and BHB.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Molecular Medicine and Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
ORCID profiles: Yoshimitsu Yura, Koji Ohashi
Funding
- Grant-in-Aid for Scientific Research A
- Takeda Science Foundation (TSF)
- Grant-in-Aid for Scientific Research C
Cite
APA
Takahara, K., Ouchi, N., Takikawa, T., Ozaki, Y., Fang, L., Kawanishi, H., Tatsumi, M., Yura, Y., Kato, K., Takefuji, M., Murohara, T., & Ohashi, K. (2025). Pemafibrate ameliorates renal injury through induction of FGF21 and ketone body production in male mice. Physiological Reports, 13(3). https://doi.org/10.14814/phy2.70135
Vancouver
Takahara K, Ouchi N, Takikawa T, Ozaki Y, Fang L, Kawanishi H, et al. Pemafibrate ameliorates renal injury through induction of FGF21 and ketone body production in male mice. Physiological Reports. 2025;13(3). doi:10.14814/phy2.70135
BibTeX
@article{Takahara2025,
author = {Takahara, Kunihiko and Ouchi, Noriyuki and Takikawa, Tomonobu and Ozaki, Yuta and Fang, Lixin and Kawanishi, Hiroshi and Tatsumi, Minako and Yura, Yoshimitsu and Kato, Katsuhiro and Takefuji, Mikito and Murohara, Toyoaki and Ohashi, Koji},
title = {Pemafibrate ameliorates renal injury through induction of FGF21 and ketone body production in male mice},
journal = {Physiological Reports},
year = {2025},
volume = {13},
number = {3},
doi = {10.14814/phy2.70135}
}
EUVIMED